MRZM — Marizyme Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Marizyme, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.06 | -5.85 | -11 | -38.2 | -65.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.729 | 1.82 | 3.44 | 28.9 | 49.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.217 | 0.209 | 1.72 | -2.48 | 9.94 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.112 | -3.22 | -5.79 | -10.9 | -4.68 |
| Capital Expenditures | -0.013 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.149 | 0 | — | — |
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.013 | -0.149 | 0 | — | — |
| Financing Cash Flow Items | 0 | — | 6.69 | 6.5 | 2.84 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.125 | 6.28 | 6.96 | 7.29 | 4.32 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0 | 2.9 | 1.17 | -3.56 | -0.362 |